RT Journal Article
SR Electronic
T1 To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 173
OP 180
DO 10.3949/ccjm.90a.22071
VO 90
IS 3
A1 Tayyab S. Khan
A1 Partha Sinha
A1 Harold Rosen
YR 2023
UL http://www.ccjm.org/content/90/3/173.abstract
AB An initial bone mineral density (BMD) measurement is used to diagnose osteoporosis and decide whether patients need treatment, but the utility of repeating this test in those on treatment or on a drug holiday (ie, during a pause in bisphosphonate treatment) is controversial. Here, we present evidence for and against the use of BMD monitoring in patients receiving antiresorptive therapy or on a drug holiday, and give our recommendations, arguing against a one-size-fits-all approach.